Kamiya Takeshi, Shikano Michiko, Tanaka Mamoru, Tsukamoto Hironobu, Ebi Masahide, Hirata Yoshikazu, Mizushima Takashi, Murakami Kenji, Shimura Takaya, Mizoshita Tsutomu, Mori Yoshinori, Tanida Satoshi, Kato Takashi, Imaeda Kenro, Kataoka Hiromi, Joh Takashi
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan.
J Smooth Muscle Res. 2011;47(3-4):79-87. doi: 10.1540/jsmr.47.79.
Omeprazole, a proton pump inhibitor, is widely used for the treatment of patients with peptic ulcer, gastroesophageal reflux disease and functional dyspepsia (FD), although some studies have demonstrated that omeprazole delays gastric emptying. The purpose of this study was to investigate the efficacy of omeprazole on gastric motility including gastric myoelectrical activity and gastric emptying. This study was performed on 12 healthy volunteers. Gastric motility was evaluated with cutaneously recorded electrogastrography (EGG) and gastric emptying of semi-solid meals using the (13)C-acetic acid breath test. EGG and gastric emptying were measured before and after treatment with 20 mg omeprazole orally for 7 days. In the fasting state, the percentage of EGG normogastria increased significantly compared to the baseline. No significant changes were observed in other EGG parameters including the percentage of tachygastria and bradygastria in both fasting and postprandial states, and the power ratios between both before and after ingestion of omeprazole. In addition, administrated omeprazole did not show any significant differences in the gastric emptying parameters such as the half emptying time. We conclude that administration of omeprazole did not affect gastric motility but improved gastric myoelectrical activity. These effects of omeprazole may be one of the mechanisms involved in its efficacy in relieving dyspeptic symptoms in FD patients.
奥美拉唑是一种质子泵抑制剂,广泛用于治疗消化性溃疡、胃食管反流病和功能性消化不良(FD)患者,尽管一些研究表明奥美拉唑会延迟胃排空。本研究的目的是探讨奥美拉唑对胃动力(包括胃肌电活动和胃排空)的疗效。本研究对12名健康志愿者进行。通过经皮记录的胃电图(EGG)和使用(13)C-乙酸呼气试验评估半固体餐的胃排空来评估胃动力。在口服20mg奥美拉唑治疗7天前后测量EGG和胃排空。在禁食状态下,与基线相比,EGG正常胃电图的百分比显著增加。在其他EGG参数方面未观察到显著变化,包括禁食和餐后状态下的心动过速和心动过缓百分比,以及服用奥美拉唑前后两者之间的功率比。此外,服用奥美拉唑后胃排空参数如半排空时间未显示任何显著差异。我们得出结论,服用奥美拉唑不会影响胃动力,但会改善胃肌电活动。奥美拉唑的这些作用可能是其缓解FD患者消化不良症状疗效的机制之一。